These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates. Arias CA; Singh KV; Panesso D; Murray BE Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057 [TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci. Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526 [TBL] [Abstract][Full Text] [Related]
6. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374 [TBL] [Abstract][Full Text] [Related]
7. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269 [TBL] [Abstract][Full Text] [Related]
8. Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity. Bayer AS; Tu J Antimicrob Agents Chemother; 1990 Jun; 34(6):1068-74. PubMed ID: 2118323 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid. Barber KE; Smith JR; Raut A; Rybak MJ J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci. Schick DG; Canawati HN; Montgomerie JZ Diagn Microbiol Infect Dis; 1997 Dec; 29(4):233-9. PubMed ID: 9458980 [TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations. Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403 [TBL] [Abstract][Full Text] [Related]
12. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin. Eliopoulos GM; Thauvin-Eliopoulos C; Moellering RC Clin Infect Dis; 1992 Jul; 15(1):58-62. PubMed ID: 1319757 [TBL] [Abstract][Full Text] [Related]
13. Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis. Hoellman DB; Visalli MA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1998 Apr; 42(4):857-61. PubMed ID: 9559796 [TBL] [Abstract][Full Text] [Related]
15. Production of A and C variants of staphylococcal beta-lactamase by methicillin-resistant strains of Staphylococcus aureus. Norris SR; Stratton CW; Kernodle DS Antimicrob Agents Chemother; 1994 Jul; 38(7):1649-50. PubMed ID: 7979301 [TBL] [Abstract][Full Text] [Related]
16. Detection of genes regulating beta-lactamase production in Enterococcus faecalis and Staphylococcus aureus. Okamoto R; Okubo T; Inoue M Antimicrob Agents Chemother; 1996 Nov; 40(11):2550-4. PubMed ID: 8913462 [TBL] [Abstract][Full Text] [Related]
17. Comparison of enterococcal and staphylococcal beta-lactamase plasmids. Wanger AR; Murray BE J Infect Dis; 1990 Jan; 161(1):54-8. PubMed ID: 2153187 [TBL] [Abstract][Full Text] [Related]
18. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. Entenza JM; Giddey M; Vouillamoz J; Moreillon P Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277 [TBL] [Abstract][Full Text] [Related]